Agrylin (Shire US Manufacturing Inc.)
Welcome to the PulseAid listing for the Agrylin drug offered from Shire US Manufacturing Inc.. This Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Shire US Manufacturing Inc. |
| NON-PROPRIETARY NAME: | anagrelide hydrochloride |
| SUBSTANCE NAME: | ANAGRELIDE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1997-03-14 |
| END MARKETING DATE: | 0000-00-00 |
Agrylin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Agrylin from Shire US Manufacturing Inc. |
| LABELER NAME: | Shire US Manufacturing Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 1997-03-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 54092-063_87ee8657-824d-48ae-835e-66c4785c61aa |
| PRODUCT NDC: | 54092-063 |
| APPLICATION NUMBER: | NDA020333 |
Other ANAGRELIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
